Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony J Hatswell

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 15, 2023
Incorporating Prior Beliefs Into Meta-Analyses of Health-State Utility Values Using the Bayesian Power PriorAnthony J Hatswell
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 27, 2025
R Packages for Matching-Adjusted Indirect Comparison: Differences in Usability and Identical Results From Reuse of Prior CodeKurt Taylor, Anthony J Hatswell
Applied Health Economics and Health Policy|December 7, 2018
Reducing Drug Wastage in Pharmaceuticals Dosed by Weight or Body Surface Areas by Optimising Vial SizesAnthony J Hatswell, Joshua K Porter
Statistical Methods in Medical Research|January 31, 2019
Creating historical controls using data from a previous line of treatment - Two non-standard approachesAnthony J Hatswell, William G Sullivan
Pharmacoeconomics|June 20, 2016
Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UKJamie Elvidge, Ash Bullement, Anthony J Hatswell
Pharmacoeconomics|October 26, 2016
Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and TaxonomyAnthony J Hatswell, Nick Freemantle, Gianluca Baio
Applied Health Economics and Health Policy|December 14, 2020
What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death ApproachesAnthony J Hatswell, Ash Bullement, Michael Schlichting, et al.
Health Economics|February 22, 2019
Frequentist and Bayesian meta-regression of health state utilities for multiple myeloma incorporating systematic review and analysis of individual patient dataAnthony J Hatswell, Darren Burns, Gianluca Baio, et al.
Pharmacoeconomics|July 13, 2022
Carers' Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and RecommendationsBecky Pennington, Jack Eaton, Anthony J Hatswell, et al.
Plos One|December 25, 2015
The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UKJames Larkin, Anthony J Hatswell, Paul Nathan, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 15, 2023
Incorporating Prior Beliefs Into Meta-Analyses of Health-State Utility Values Using the Bayesian Power PriorAnthony J Hatswell
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 27, 2025
R Packages for Matching-Adjusted Indirect Comparison: Differences in Usability and Identical Results From Reuse of Prior CodeKurt Taylor, Anthony J Hatswell
Applied Health Economics and Health Policy|December 7, 2018
Reducing Drug Wastage in Pharmaceuticals Dosed by Weight or Body Surface Areas by Optimising Vial SizesAnthony J Hatswell, Joshua K Porter
Statistical Methods in Medical Research|January 31, 2019
Creating historical controls using data from a previous line of treatment - Two non-standard approachesAnthony J Hatswell, William G Sullivan
Pharmacoeconomics|June 20, 2016
Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UKJamie Elvidge, Ash Bullement, Anthony J Hatswell
Pharmacoeconomics|October 26, 2016
Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and TaxonomyAnthony J Hatswell, Nick Freemantle, Gianluca Baio
Applied Health Economics and Health Policy|December 14, 2020
What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death ApproachesAnthony J Hatswell, Ash Bullement, Michael Schlichting, et al.
Health Economics|February 22, 2019
Frequentist and Bayesian meta-regression of health state utilities for multiple myeloma incorporating systematic review and analysis of individual patient dataAnthony J Hatswell, Darren Burns, Gianluca Baio, et al.
Pharmacoeconomics|July 13, 2022
Carers' Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and RecommendationsBecky Pennington, Jack Eaton, Anthony J Hatswell, et al.
Plos One|December 25, 2015
The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UKJames Larkin, Anthony J Hatswell, Paul Nathan, et al.
Pageof 4